Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6224690 | 0.80 | TSHR (0.43) | TSHRCYP2D6CYP2C19LMNAMAPK1 | |
| SCHEMBL4422682 | 0.80 | HTR2A (0.36) | CYP2C19HTR2AKMT2A | |
| SCHEMBL15481931 | 0.78 | TSHR (0.41) | TSHRCYP2D6CYP2C19HTR2ATAAR1 | |
| SCHEMBL26127277 | 0.78 | IDO1 (0.34) | — | |
| SCHEMBL6223277 | 0.78 | CYP2A6 (0.38) | LMNAALDH1A1KMT2A | |
| SCHEMBL6221926 | 0.78 | IDO1 (0.34) | — | |
| SCHEMBL68782 | 0.78 | HTR2A (0.46) | TSHRCYP2D6CYP2C19HTR2ATAAR1 | |
| SCHEMBL2923052 | 0.77 | CYP2C19 (0.52) | TSHRCYP2C19HTR2ATAAR1KDM4E | |
| SCHEMBL2371653 | 0.77 | TSHR (0.44) | TSHRCYP2C19HTR2ATAAR1LMNA | |
| SCHEMBL3140559 | 0.76 | CYP2D6 (0.42) | TSHRCYP2D6CYP2C19HTR2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2641923-B1 | (Co)-polymeric and hybrid (co)-polymeric electron acceptors for organic photovoltaic cell applications | UNIV OF PATRAS (GR) | 2017-05-24 | — | — | EP | disclosed |
| EP-2641923-A1 | (Co)-polymeric and hybrid (co)-polymeric electron acceptors for organic photovoltaic cell applications | University Of Patras (GR) | 2013-09-25 | — | — | EP | disclosed |
| US-6624196-B2 | Particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of multiple sclerosis, cardiovascular disorders | WARNER-LAMBERT COMPANY | 2003-09-23 | — | — | US | disclosed |
| US-6541521-B1 | Particularly gelatinase A, collagenase-3, and stromelysin-1 | WARNER-LAMBERT COMPANY | 2003-04-01 | — | — | US | disclosed |
| US-20020161050-A1 | Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases | WARNER-LAMBERT COMPANY (US) | 2002-10-31 | — | — | US | disclosed |
| WO-2000075094-A2 | METHOD FOR PRODUCING A HALOGENATED ACETOPHENONE | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000037425-A1 | METHOD FOR PRODUCING FLUOXETIN | SIEGFRIED CMS AG (CH) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161050-A1 | Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases | MMP1, MMP8, MMP13 | TSHR 3908/4885CYP2D6 1486/4885CYP2C19 2290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.